Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment-Reference-Cited by-同舟云学术

Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment

Published:2021-03 Issue: Volume:153 Page:108-116
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ohtaki Yoichi,Shimizu Kimihiro,Suzuki Hiroyuki,Suzuki Kenji,Tsuboi Masahiro,Mitsudomi Tetsuya^ORCID,Takao Motoshi^ORCID,Murakawa Tomohiro^ORCID,Ito Hiroyuki,Yoshimura Kenichi,Okada Morihito,Chida Masayuki^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol.,2010

2. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

3. Understanding and targeting resistance mechanisms in NSCLC;Rotow;Nat. Rev. Cancer,2017

4. Salvage surgery for advanced non-small cell lung cancer after response to gefitinib;Hishida;J. Thorac. Cardiovasc. Surg.,2010

5. Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment;Shen;Clin. Respir. J.,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary: Re-consult surgery for patients with lung cancer? The role of resection after initial nonoperative therapy;The Journal of Thoracic and Cardiovascular Surgery;2024-08

2. Salvage lung resection after immunotherapy is feasible and safe;JTCVS Open;2024-08

3. Salvage surgery following tyrosine kinase inhibitor treatment for advanced non-small cell lung cancer;Surgical Case Reports;2024-06-20

4. Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery;Surgery Today;2024-03-14

5. Prognosis of non‐small cell lung cancer with postoperative regional lymph node recurrence;Thoracic Cancer;2024-02-27